Streetbeat News

Stock Prices

COCH

Envoy Medical, a company focused on fully implanted hearing devices, has secured a $10 million lending facility, drawing $5 million initially. This funding, provided by major shareholder Glen Taylor, supports the company's growth and milestone achievements.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:07 pm

ASTS

AST SpaceMobile (NASDAQ:ASTS) will redeem all outstanding publicly traded warrants for $0.01 each on September 27, 2024, after meeting the stock price condition of at least $18.00 for 20 days within a 30-day period. Warrant holders can exercise their warrants for $11.50 each until the redemption date.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:06 pm

VXRT

Vaxart has announced promising preclinical data for its mucosal vaccine technology, which shows potential in treating HPV-related tumors. The vaccine stimulated an immune response, reduced tumor size, and increased survival in an animal model, indicating potential for non-invasive treatment of HPV-related cervical dysplasia.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:04 pm

FL

Foot Locker reported a Q2 adjusted EPS loss of 5 cents, beating expectations, and sales of $1.896 billion, also surpassing estimates. Despite positive sales growth and margin expansion, the stock fell 8.11% premarket due to store closures and a cautious outlook.

Portfolio Pulse from Anusuya Lahiri

August 28, 2024 | 12:03 pm

ASTS

AST SpaceMobile announced it will redeem all publicly traded warrants to purchase Class A common shares that remain outstanding as of 5:00 p.m. on September 27.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:03 pm

LEGN

Legend Biotech (NASDAQ:LEGN) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has increased to $77.93. The company has shown significant revenue growth but faces challenges in ROE and ROA.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 12:01 pm

MMSI

Merit Medical Systems (NASDAQ:MMSI) has received mixed analyst ratings over the past three months, with a majority being bullish or somewhat bullish. Analysts have set a 12-month average price target of $100.56, indicating a positive outlook. The company shows strong financial health with impressive net margins and efficient asset utilization.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 12:00 pm

CTSH

Cognizant Tech Solns (NASDAQ:CTSH) received neutral ratings from six analysts, with price targets ranging from $72 to $82, reflecting a slight upward trend. Despite a recent revenue decline, the company shows strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 12:00 pm

SNOA

Sonoma Pharmaceuticals shares are trading lower following the announcement of a 1-for-20 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:54 am

BZUN

Baozun Inc (NASDAQ: BZUN) reported a 3.1% revenue growth in Q2 2024, surpassing analyst expectations. Despite an adjusted loss per ADS, the stock price rose due to increased service revenue and a positive outlook from the CEO. The company is focusing on revitalization efforts and a partnership with Gap Inc.

Portfolio Pulse from Anusuya Lahiri

August 28, 2024 | 11:52 am